Drugs giant AstraZeneca has revealed plans to overhaul its US listing, but stressed it will keep its headquarters in the UK and remain on the London market. Cambridge-based AstraZeneca is set to ...
AstraZeneca on Thursday appointed company insider Rick Suarez as the head of its U.S. biopharmaceuticals unit to lead the ...
AstraZeneca has named Rick R. Suarez as Senior Vice President, U.S. President and Head of the U.S. Biopharmaceuticals ...
A view of a helmet with the AstraZeneca logo next to a bust of former U.S. President Abraham Lincoln on the day of an announcement about lowering U.S. drug prices, at the White House in Washington, ...
WILMINGTON, Del.--(BUSINESS WIRE)-- AstraZeneca (AZN) today announces the launch of AstraZeneca Direct, an online platform designed to create a simple, convenient way for eligible patients to access ...
Only 40% of new medicines are currently available in Europe, compared with 85% in the United States. AstraZeneca executive, ...
WILMINGTON, Del.--(BUSINESS WIRE)--AstraZeneca’s IMFINZI ® (durvalumab) in combination with standard-of-care FLOT chemotherapy (fluorouracil, leucovorin, oxaliplatin, and docetaxel) has been approved ...
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D AstraZeneca today announces plans to invest $2 ...
In July, AstraZeneca announced plans to invest $50 billion by 2030 on boosting its US manufacturing and research operations - Copyright AFP Tobias SCHWARZ In July ...
Fourth major US manufacturing investment announced this year, advancing AstraZeneca’s historic $50 billion commitment to medicines manufacturing and R&D The Frederick facility currently produces ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback